Why the study?
Statin therapy reduces cardiovascular event risk, but the relationship between preoperative chronic statin administration and postoperative 2-month heart transplantation complications required investigation.
Does preoperative chronic statin therapy reduce postoperative 2-month complications in heart transplant recipients?
Does preoperative chronic statin therapy reduce postoperative 2-month complications in heart transplant recipients?
Preoperative chronic statin therapy may protect against 2-month postoperative complications in heart transplant recipients, though it may increase the risk of early postoperative AKI and T2DM.
Answers are grounded in this paper and cite their sources.
Preoperative statin use was associated with fewer early post-HTx complications; hypothesis-generating and should not yet change practice.
Background: Statin therapy has been proven to reduce the risk of cardiovascular events. The objective of our retrospective study was to investigate the relationship between preoperative chronic administration of statins to postoperative 2-month heart transplantation complications. Methods: A total number of 38 heart transplantation recipients from the Cardiovascular and Transplant Emergency Institute of Târgu Mureș between May 2014 and January 2021 were included in our study. Results: In logistic regression, we found a statistical significance between statin treatment and the presence of postoperative complications of any cause (OR: 0.06, 95% CI: 0.008–0.56; p = 0.0128), simultaneously presenting an elevated risk for early-postoperative acute kidney injury (AKI). From the statin group, atorvastatin therapy had a higher risk of type 2 diabetes mellitus (T2DM) development (OR: 29.73, 95% CI: 1.19–741.76; p = 0.0387) and AKI (OR: 29.73, 95% CI: 1.19–741.76; p = 0.0387). C-reactive protein (CRP), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-c) represented risk factors, atorvastatin administration being independently associated with lower CRP values. Conclusions: Chronic previous administration of statins represented a protective factor to the development of 2-month postoperative complications of any cause in heart transplant receipts.
No takes yet. Share an insight, caveat, or question.
Babă et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: